[1]
H. Lu, P. Meyer, and R. Hullin, “Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how? A narrative literature review”, Swiss Med Wkly, vol. 150, no. 3536, p. w20341, Sep. 2020.